EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.3.3.8 | 3,3,14,14-tetramethylhexadecanedioic acid | i.e. Medica-16 | Rattus norvegicus | |
2.3.3.8 | GSSG | inactivation involves formation of a protein-protein disulfide rather than a protein-glutathione complex | Rattus norvegicus |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.3.3.8 | 0.0042 | - |
CoA | - |
Rattus norvegicus | |
2.3.3.8 | 0.11 | - |
citrate | - |
Rattus norvegicus | |
2.3.3.8 | 0.2 | - |
ATP | - |
Rattus norvegicus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.3.3.8 | Rattus norvegicus | - |
- |
- |
EC Number | Oxidation Stability | Organism |
---|---|---|
2.3.3.8 | the enzyme is in equilibrium between an oxidized inactive form and a reduced active form | Rattus norvegicus |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.3.3.8 | liver | - |
Rattus norvegicus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.3.3.8 | ATP + citrate + CoA | - |
Rattus norvegicus | ADP + phosphate + acetyl-CoA + oxaloacetate | - |
? |